Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
|---|---|---|---|---|---|---|---|---|---|
45 | 19/12/2019 15:38:29 | Male | hepatic encephalopathy, col, upper gi bleeding | metronidazole | 0.75 | IV | TDS | 1 | col |
45 | 19/12/2019 15:37:32 | Male | hepatic encephalopathy, col, upper gi bleeding | ceftriaxone | 1 | IV | BD | 2 | col |
66 | 19/12/2019 16:22:51 | Male | alcoholic gastritis, early col, hypertension | amoxicillin | 0.5 | Oral | BD | 14 | col |
66 | 19/12/2019 16:23:58 | Male | alcoholic gastritis, early col, hypertension | clarithromycin | 0.5 | Oral | BD | 14 | col |
48 | 19/12/2019 15:37:12 | Female | he, rvi with col | ceftriaxone | 1 | IV | OD | 8 | col |
48 | 19/12/2019 15:40:22 | Female | he, rvi with col | levofloxacin | 0.25 | IV | OD | 3 | col |
48 | 19/12/2019 15:34:56 | Female | he, rvi with col | ceftriaxone | 1 | IV | BD | 8 | col |
48 | 19/12/2019 15:38:59 | Female | he, rvi with col | levofloxacin | 0.5 | IV | OD | 8 | col |
48 | 19/12/2019 15:41:27 | Female | he, rvi with col | rifaximin | 0.55 | Oral | BD | 1 | col |
48 | 19/12/2019 14:17:07 | Female | confusion, liver impairment,esophagocutaneous fistula | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 7 | confusion |
48 | 19/12/2019 14:18:00 | Female | confusion, liver impairment,esophagocutaneous fistula | streptomycin | 1 | IM | OD | 1 | confusion |
48 | 19/12/2019 14:18:35 | Female | confusion, liver impairment,esophagocutaneous fistula | levofloxacin | 0.75 | Oral | OD | 1 | confusion |
67 | 19/12/2019 14:07:43 | Female | consolidation, chest infection, aki | co-amoxiclav | 1.2 | IV | TDS | 5 | consolidation |
67 | 19/12/2019 14:08:14 | Female | consolidation, chest infection, aki | clarithromycin | 0.5 | Oral | BD | 10 | consolidation |
63 | 19/12/2019 14:46:07 | Male | acute copd, chest infection | ceftazidime | 1 | IV | TDS | 4 | copd |
63 | 19/12/2019 14:47:41 | Male | acute copd, chest infection | clarithromycin | 1 | Oral | BD | 1 | copd |
63 | 19/12/2019 14:48:52 | Male | acute copd, chest infection | cefixime | 1 | Oral | BD | 7 | copd |
67 | 19/12/2019 16:29:26 | Female | dm, copd, koch's lung, cor pulmonale | ceftriaxone | 1 | IV | BD | 3 | copd |
67 | 19/12/2019 16:30:06 | Female | dm, copd, koch's lung, cor pulmonale | cefixime | 0.02 | Oral | BD | 5 | copd |
53 | 19/12/2019 16:16:27 | Female | copd, chest infection, ihd, hypertension, newly dx dm | co-amoxiclav | 1.2 | IV | TDS | 3 | copd |
53 | 19/12/2019 16:17:09 | Female | copd, chest infection, ihd, hypertension, newly dx dm | ceftriaxone | 1 | IV | BD | 2 | copd |
53 | 19/12/2019 16:18:06 | Female | copd, chest infection, ihd, hypertension, newly dx dm | levofloxacin | 0.5 | Oral | OD | 7 | copd |
52 | 19/12/2019 16:22:22 | Male | chest infection, copd | ceftriaxone | 1 | IV | BD | 4 | copd |
52 | 19/12/2019 16:23:50 | Male | chest infection, copd | clarithromycin | 0.5 | Oral | BD | 4 | copd |
52 | 19/12/2019 16:25:33 | Male | chest infection, copd | co-amoxiclav | 2 | IV | TDS | 4 | copd |
65 | 19/12/2019 16:22:50 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 1 | IV | TDS | 1 | copd |
65 | 19/12/2019 16:24:34 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 0.625 | Oral | TDS | 2 | copd |
65 | 19/12/2019 16:25:18 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | clarithromycin | 0.5 | Oral | BD | 4 | copd |
65 | 19/12/2019 16:25:52 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | ceftriaxone | 1 | IV | BD | 2 | copd |
74 | 19/12/2019 14:51:34 | Female | copd, chest infection | ceftazidime | 1 | IV | TDS | 1 | copd |
78 | 19/12/2019 14:00:59 | Male | copd, chest infection, cardiogenic shock | co-amoxiclav | 1.2 | IV | TDS | 1 | copd |
67 | 19/12/2019 13:56:04 | Male | copd, cor pulmonale, ihd, koch’s lung | ceftazidime | 1 | IV | TDS | 5 | copd |
58 | 19/12/2019 14:14:42 | Male | copd, piles, cva | ceftazidime | 1 | IV | TDS | 6 | copd |
78 | 19/12/2019 14:12:19 | Male | lung consodilation(rlz) , COPD | co-amoxiclav | 1.2 | IV | TDS | 1 | copd |
78 | 19/12/2019 14:13:33 | Male | lung condilation(rlz), CPOD | clarithromycin | 0.5 | Oral | BD | 10 | copd |
72 | 19/12/2019 14:37:41 | Female | copd ppt chest infection, old Koch,s lung | co-amoxiclav | 1.2 | IV | TDS | 1 | copd, chest infection |
72 | 19/12/2019 14:36:39 | Female | copd ppt chest infection, koch's lung | ceftriaxone | 1 | IV | TDS | 5 | copd, chest infection |
67 | 19/12/2019 13:56:04 | Male | copd, cor pulmonale, ihd, koch’s lung | ceftazidime | 1 | IV | TDS | 5 | cor pulmonale |
33 | 19/12/2019 16:17:27 | Male | cryptococcal meningitis, pre-renal acute kidney injury, rvi stage 4 | ceftriaxone | 2 | IV | BD | 6 | cryptococcal meningitis |
33 | 19/12/2019 16:19:50 | Male | cryptococcal meningitis, pre-renal acute kidney injury, rvi stage 4 | septrin | 0.96 | Oral | OD | 5 | cryptococcal meningitis |
67 | 19/12/2019 14:39:41 | Female | uti , mi, dm, ckd, cuf, cff ppt by chest infection | ceftriaxone | 1 | IV | BD | 7 | cuf |
58 | 19/12/2019 14:14:42 | Male | copd, piles, cva | ceftazidime | 1 | IV | TDS | 6 | cva |
69 | 19/12/2019 14:04:40 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | metronidazole | 0.75 | IV | TDS | 5 | deep vein thrombosis of left leg |
69 | 19/12/2019 14:08:30 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | cefipime | 1 | IV | BD | 1 | deep vein thrombosis of left leg |
86 | 19/12/2019 14:08:09 | Female | haemoptysis, TB , degenerative mr | co-amoxiclav | 1.2 | IV | TDS | 3 | degenerative mr |
23 | 19/12/2019 15:55:03 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | clindamycin | 150 | Oral | TDS | 5 | dental caries |
23 | 19/12/2019 15:50:16 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | ceftriaxone | 1 | IV | BD | 1 | dental caries |
13 | 19/12/2019 14:16:41 | Male | T/T for prolong fever, dengue fever | ceftriaxone | 0.5 | IV | BD | 4 | dhf |
13 | 19/12/2019 14:18:15 | Male | T/T for prolong fever, dengue fever | cefixime | 0.2 | Oral | BD | 3 | dhf |
13 | 19/12/2019 14:31:22 | Male | DHF | cefixime | 0.2 | Oral | BD | 5 | dhf |
14 | 19/12/2019 16:08:15 | Male | dhf | cefixime | 0.2 | Oral | BD | 5 | dhf |
13 | 19/12/2019 14:30:26 | Male | DHF | ceftriaxone | 1 | IV | BD | 4 | dhf |
15 | 19/12/2019 14:42:54 | Male | dhf with warning signs | ceftriaxone | 1 | IV | BD | 7 | dhf |
15 | 19/12/2019 14:45:38 | Male | dhf with warning signs | metronidazole | 0.75 | IV | TDS | 7 | dhf |
23 | 19/12/2019 15:55:03 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | clindamycin | 150 | Oral | TDS | 5 | discharge fits |
23 | 19/12/2019 15:50:16 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | ceftriaxone | 1 | IV | BD | 1 | discharge fits |
29 | 19/12/2019 15:11:11 | Female | discharge uti | ciprofloxacin | 0.5 | Oral | OD | 1 | discharge uti |
41 | 19/12/2019 15:47:25 | Male | right leg cellulitis, col, duodenal erosion, rvi satge | amoxicillin+flucoxacillin | 0.5 | Oral | TDS | 5 | duodenal erosion |
41 | 19/12/2019 15:43:49 | Male | right leg cellulitis, col, duodenal erosion, rvi stage 2 | amoxicillin+flucloxacillin | 1 | IV | QID | 8 | duodenal erosion |
41 | 19/12/2019 15:46:19 | Male | right leg cellulitis, col, duodenal erosion, rvi satge 2 | clindamycin | 0.5 | Oral | TDS | 1 | duodenal erosion |
90 | 19/12/2019 15:04:30 | Female | sick sinus syndrome, ccf, poor drug adherence, ihd | ceftriaxone | 1 | IV | BD | 4 | dyspnoea |
30 | 19/12/2019 15:03:36 | Female | rhd, severe ms, mild tr, severe pol ht, large slot in la, on warfarinization | pen v | 0.25 | Oral | BD | 1 | dyspnoea |
90 | 19/12/2019 15:08:08 | Female | sick sinus syndrome, ccf, poor drug adherence, ihd | cefixime | 0.2 | Oral | BD | 3 | dyspnoea |
19 | 19/12/2019 16:18:07 | Male | electrocution left hand | amoxicillin+flucloxacillin | 0.25 | Oral | TDS | 5 | electrocution left hand |
54 | 19/12/2019 14:45:52 | Female | hydropneumothorax, empyema, type 2 dm, myoma uterus | metronidazole | 0.75 | IV | TDS | 1 | empyema |
54 | 19/12/2019 14:47:44 | Female | hydropneumothorax, empyema, type 2 dm, myoma uterus | co-amoxiclav | 1.2 | IV | TDS | 14 | empyema |
48 | 19/12/2019 14:17:07 | Female | confusion, liver impairment,esophagocutaneous fistula | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 7 | esophagocutaneous fistula |
48 | 19/12/2019 14:18:00 | Female | confusion, liver impairment,esophagocutaneous fistula | streptomycin | 1 | IM | OD | 1 | esophagocutaneous fistula |
48 | 19/12/2019 14:18:35 | Female | confusion, liver impairment,esophagocutaneous fistula | levofloxacin | 0.75 | Oral | OD | 1 | esophagocutaneous fistula |
52 | 19/12/2019 15:35:57 | Male | ESRD | cefixime | 0.2 | Oral | BD | 5 | esrd |
52 | 19/12/2019 15:37:25 | Male | esrd | co-amoxiclav | 0.6 | Oral | OD | 1 | esrd |
52 | 19/12/2019 15:39:08 | Male | esrd | co-amoxiclav | 1.2 | IV | OD | 1 | esrd |
52 | 19/12/2019 15:42:06 | Male | esrd | ceftriaxone+sulbactam | 1 | IV | BD | 4 | esrd |
38 | 19/12/2019 15:26:31 | Male | alcohol withdrawal, extensive koch's lung, septic shock ē lrti | cefoparazone+sulbactam | 2 | IV | BD | 10 | extensive koch's lung |
23 | 19/12/2019 15:55:03 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | clindamycin | 150 | Oral | TDS | 5 | facial injury |
23 | 19/12/2019 15:50:16 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | ceftriaxone | 1 | IV | BD | 1 | facial injury |
19 | 19/12/2019 15:09:44 | Female | avi | ceftriaxone | 1 | IV | BD | 2 | fainting attack |
28 | 19/12/2019 14:10:33 | Male | febrile convulsion d/t avi | cefixime | 0.06 | Oral | BD | 1 | febrile convulsion d/t avi |
1 | 19/12/2019 16:00:42 | Male | fever with malaena | flucloxacillin | 0.125 | Oral | BD | 1 | fever |
22 | 19/12/2019 16:19:10 | Male | fever with capopedal spasm | ceftriaxone | 1 | IV | BD | 3 | fever |
22 | 19/12/2019 16:19:52 | Male | fever with capopedal spasm | cefixime | 0.2 | Oral | BD | 5 | fever |
70 | 19/12/2019 15:46:17 | Male | avi | ceftriaxone | 2 | IV | BD | 7 | fever |
70 | 19/12/2019 15:47:31 | Male | avi | levofloxacin | 0.25 | IV | OD | 7 | fever |
70 | 19/12/2019 15:48:18 | Male | avi | metronidazole | 0.75 | IV | TDS | 7 | fever |
63 | 19/12/2019 13:58:49 | Female | fever, dyspnoea | imipenem | 0.5 | IV | TDS | 7 | fever |
22 | 19/12/2019 15:13:40 | Male | malaria | ceftriaxone | 1 | IV | BD | 4 | fever |
22 | 19/12/2019 15:14:19 | Male | malaria | doxycycline | 0.1 | Oral | BD | 7 | fever |
19 | 19/12/2019 14:58:55 | Male | avi | co-amoxiclav | 0.625 | Oral | TDS | 3 | fever |
70 | 19/12/2019 14:04:55 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftriaxone | 1 | IV | BD | 2 | fever |
70 | 19/12/2019 14:05:42 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | amikacin | 0.5 | IV | BD | 8 | fever |
70 | 19/12/2019 14:06:17 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftazidime | 2 | IV | TDS | 2 | fever |
48 | 19/12/2019 15:41:27 | Female | he, rvi with col | rifaximin | 0.55 | Oral | BD | 1 | fever |
15 | 19/12/2019 15:07:34 | Male | flaccid paraparesis | amoxicillin+flucloxacillin | 0.5 | Oral | QID | 1 | flaccid paraparesis |
32 | 19/12/2019 14:35:20 | Male | food poisoing, acute GE, some dehydration | norfloxacin | 0.4 | Oral | BD | 3 | food poisoing |
47 | 19/12/2019 15:15:38 | Male | centipede bite | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 1 | for killing according bacteria |
43 | 19/12/2019 15:32:12 | Male | hma, dm, dkd | clarithromycin | 0.5 | Oral | BD | 14 | for ogd scopy |
43 | 19/12/2019 15:33:08 | Male | hma, dm, dkd | amoxiclav | 1 | Oral | BD | 14 | for ogd scopy |
53 | 19/12/2019 14:48:01 | Male | b(+), col, gastritis | ceftriaxone | 1 | IV | BD | 1 | gastritis |
32 | 19/12/2019 16:14:45 | Female | general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+) | co-amoxiclav | 1.2 | IV | TDS | 2 | general debility e excessive vomitting |
32 | 19/12/2019 16:15:20 | Female | general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+) | co-amoxiclav | 0.6 | Oral | OD | 2 | general debility e excessive vomitting |